{"count":2,"next":null,"previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/e667aaf5-9cab-46b6-bb14-0390e0752c3d/","filing_uuid":"e667aaf5-9cab-46b6-bb14-0390e0752c3d","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/e667aaf5-9cab-46b6-bb14-0390e0752c3d/print/","filing_document_content_type":"text/html","income":"146407.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Marc Schloss","dt_posted":"2026-10-13T16:13:32-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1625 Eye Street NW","registrant_address_2":"Suite 600","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":29403,"url":"https://lda.gov/api/v1/registrants/29403/","house_registrant_id":31286,"name":"CONSUMER HEALTHCARE PRODUCTS ASSOCIATION","description":null,"address_1":"1625 Eye Street NW","address_2":"Suite 600","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID SPANGLER","contact_telephone":"+1 202-429-9260","dt_updated":"2026-07-21T16:32:20.489822-04:00"},"client":{"id":134698,"url":"https://lda.gov/api/v1/clients/134698/","client_id":12,"name":"CONSUMER HEALTHCARE PRODUCTS ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-08"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act H.R.6868 - ACCESS Through OTC Innovation Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule H.R. 10336 - Dietary Supplement Innovation Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65083,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"SCHLOSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67610,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":"CHARLES","last_name":"SPANGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148255,"prefix":null,"prefix_display":null,"first_name":"JOLIE","nickname":null,"middle_name":null,"last_name":"BROCHIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"H.R.4958 - GRAS Act S.3122 - Better FDA Act of 2025 H.R. 7291 - GRAS Oversight and Transparency Act H.R. 8385 - Food Labeling Modernization Act of 2026 H.R. 8370 - Dietary Supplement Listing Act of 2026 H.R. 5027 - Ban Harmful Food Dyes Act H.R. 3722 - Do or Dye Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65083,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"SCHLOSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67610,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":"CHARLES","last_name":"SPANGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148255,"prefix":null,"prefix_display":null,"first_name":"JOLIE","nickname":null,"middle_name":null,"last_name":"BROCHIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"- The SHOP SAFE Act - Advocacy to protect funding for the Office of the Intellectual Property Enforcement Coordinator (IPEC) and to advocate for an IPEC appointment before the end of the year. - Proposed legislation on illicit trade for consumer healthcare products","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65083,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"SCHLOSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67610,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":"CHARLES","last_name":"SPANGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148255,"prefix":null,"prefix_display":null,"first_name":"JOLIE","nickname":null,"middle_name":null,"last_name":"BROCHIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"- H.R. 1219, Oral Health Products Inclusion Act - S.4587, Dietary Supplements Access Act - H.R.8933, Dietary Supplements Access Act - Pharmaceutical Tariffs - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65083,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"SCHLOSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67610,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":"CHARLES","last_name":"SPANGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148255,"prefix":null,"prefix_display":null,"first_name":"JOLIE","nickname":null,"middle_name":null,"last_name":"BROCHIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"- Pharmaceutical Tariffs","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65083,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"SCHLOSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67610,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":"CHARLES","last_name":"SPANGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148255,"prefix":null,"prefix_display":null,"first_name":"JOLIE","nickname":null,"middle_name":null,"last_name":"BROCHIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/5365ef14-38a7-46f6-bb93-864fad8aaa27/","filing_uuid":"5365ef14-38a7-46f6-bb93-864fad8aaa27","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/5365ef14-38a7-46f6-bb93-864fad8aaa27/print/","filing_document_content_type":"text/html","income":null,"expenses":"70000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Julia Gustafson - Vice President, Government Relations","dt_posted":"2026-10-19T14:05:01-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1828 L STREET, NW","registrant_address_2":"SUITE 220","registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20036","registrant":{"id":11036,"url":"https://lda.gov/api/v1/registrants/11036/","house_registrant_id":32051,"name":"COUNCIL FOR RESPONSIBLE NUTRITION","description":null,"address_1":"1828 L STREET, NW","address_2":"SUITE 220","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20036","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JULIA GUSTAFSON","contact_telephone":"+1 202-204-7690","dt_updated":"2026-07-28T10:35:13.824263-04:00"},"client":{"id":114917,"url":"https://lda.gov/api/v1/clients/114917/","client_id":12,"name":"COUNCIL FOR RESPONSIBLE NUTRITION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"All efforts related to the inclusion of dietary supplement purchases within tax-deductible Health Savings Accounts and Flexible Spending Accounts (HSAs/FSAs), including S. 4587 and H.R. 8933, the Dietary Supplements Access Act of 2026. Issues related to IRS guidance on the classification of dietary supplements as qualified medical expenses for HSAs and FSAs (IRS Publication 502).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143235,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":null,"last_name":"MISTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72578,"prefix":null,"prefix_display":null,"first_name":"JULIA","nickname":null,"middle_name":"L","last_name":"GUSTAFSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141115,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"DAVID","last_name":"MEIROVITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to the prevention of the inclusion of illicit substances like tianeptine in dietary supplements. Mandatory product listing requirements for dietary supplements, including S. 3677 and H.R. 8370, the Dietary Supplement Listing Act of 2026. Issues related to P.L. 103-417, the Dietary Supplement Health and Education Act of 1994 drug preclusion provision, including H.R. 10336, the Dietary Supplement Innovation Act of 2026. Issues related to federal preemption of state requirements applicable to dietary supplements, including H.R. 7366, the Dietary Supplement Regulatory Uniformity Act. Issues related to the generally recognized as safe (GRAS) process. Issues related to FDA's \"Simple Reform\" reorganization and its impact on dietary supplement facility inspections and specialized inspectional expertise. General issues related to the dietary supplement industry.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143235,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":null,"last_name":"MISTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72578,"prefix":null,"prefix_display":null,"first_name":"JULIA","nickname":null,"middle_name":"L","last_name":"GUSTAFSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141115,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"DAVID","last_name":"MEIROVITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to tariffs and impact on the dietary supplement industry.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143235,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":null,"last_name":"MISTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72578,"prefix":null,"prefix_display":null,"first_name":"JULIA","nickname":null,"middle_name":"L","last_name":"GUSTAFSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141115,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"DAVID","last_name":"MEIROVITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"ENV","general_issue_code_display":"Environment/Superfund","description":"Issues related to recycled materials policy and environmental attribution, including H.R.7502, The Recycled Materials Attribution Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72578,"prefix":null,"prefix_display":null,"first_name":"JULIA","nickname":null,"middle_name":"L","last_name":"GUSTAFSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143235,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":null,"last_name":"MISTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141115,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"DAVID","last_name":"MEIROVITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Monitored any issues related to the dietary supplements industry, including H.R.8962, The PERFECT Act of 2026.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143235,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":null,"last_name":"MISTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72578,"prefix":null,"prefix_display":null,"first_name":"JULIA","nickname":null,"middle_name":"L","last_name":"GUSTAFSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141115,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"DAVID","last_name":"MEIROVITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}